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Abstract
Objective: Self-report measures of health status predict
mortality in several groups of patients with cardiovascular disease,
although overlap with symptoms of depression may reduce or
eliminate this relationship. The association between self-reported
health status and mortality has not been examined in patients
hospitalized for acute coronary syndrome (ACS). The objective
was to investigate whether the Physical Component Summary
(PCS) and Mental Component Summary (MCS) scores of the SF-
12 predicted 12-month all-cause mortality after controlling for
cardiac risk factors and symptoms of depression. Methods: The
SF-12 and Beck Depression Inventory were administered 2-5 days
after admission to 800 ACS patients from 12 coronary care units.
Logistic regression was used to assess the relationship of the PCS
and MCS with mortality 12 months later, controlling for age, sex,
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cardiac diagnosis (acute myocardial infarction vs. unstable angina),
Killip class, history of myocardial infarction, and in-hospital
depressive symptoms. Results: Lower scores on the SF-12 PCS
(worse health) were associated with a significantly higher risk of
mortality [odds ratio (OR)=0.94, 95% confidence interval
(CI)=0.92-0.97, P<.OOI]. MCS scores failed to reach significance
(OR=0.98, CI=0.95-1.00, P=.053). The PCS significantly pre-
dicted mortality even after controlling for other cardiac risk factors
and depressive symptoms (OR=0.96, CI=0.93-0.99, P=.008),
equivalent to a 34% increase in risk per lO-point (I SD) decrement
in PCS scores. Conclusion: The brief SF-12 PCS presents an
attractive option for improving risk stratification among hospita-
lized ACS patients.
Introduction
Patient-reported health measures are increasingly being
integrated into clinical practice and decision-making pro-
cesses [1-3]. One reason for this is the recognition that
"hard" outcomes like physiological measures may not
always reflect all aspects of health. For example, pain,
fatigue, depression, and ability to function are of great
importance to patients but cannot be measured without
patient evaluation. Global measures of health status have
been designed to reflect health status and function as
perceived by patients across domains of health that are
important for patients [4]. For many patients with cardio-
vascular disease, health status is as important as survival [5].
Measures ofpatient-reported health status, such as the SF-36
[6] or the SF-12 [7], are widely used to evaluate the impact of
a disease on patient well-being and as outcomes measures in
studies ofmedical interventions. In addition, patient-reported
health status may be useful as a prognostic or risk
stratification tool to quantifY underlying aspects of health
not captured by overt indicators of disease severity or other
standard risk factors [8].
Patient-reported health status has been shown to inde-
pendently predict adverse outcomes, including mortality, in
studies of patients following coronary artery bypass graft
surgery [4], with stable coronary artery disease [9], and with
heart failure [10-15]. Two studies of heart failure patients
included symptoms of depression as a covariate, however,
and both found that health status no longer predicted survival
after controlling for depressive symptoms [16,17]. This is
important because many studies have reported that depres-
sion is a significant predictor of mortality among patients
with an acute coronary syndrome (ACS) [18-20]. The term
ACS refers to an episode of acute myocardial ischemia,
either with or without death or irreversible necrosis of heart
muscle. ACS includes unstable angina (UA), in which
myocardial ischemia is not severe or prolonged enough to
cause detectable necrosis of heart muscle, and myocardial
infarction (MI) in which detectable necrosis can be
demonstrated. Acute myocardial infarction (AMI), in turn,
is categorized based on the appearance of the electrocardio-
gram as either non-ST-segment elevation MI or ST-segment
elevation MI [21]. No studies have investigated whether
patient-reported health status assessed during hospitalization
for ACS predicts post-discharge mortality, and, if so,
whether it continues to predict mortality after controlling
for prognostic variables that have been shown to affect
survival, including symptoms of depression. The objective
of this study was to investigate whether the Physical
Component Summary and Mental Component Summary
scores (PCS and MCS) ofthe SF-12 [7], a briefversion ofthe
widely used SF-36 [6], predicted 12-month all-cause
mortality following ACS after controlling for other impor-
tant risk factors, including symptoms of depression. We
hypothesized that both the PCS and MCS would be
significantly associated with mortality, but that the MCS
would no longer be associated with mortality after control-
ling for depressive symptoms due to substantial overlap
between the two variables.
Methods
Patients and procedures
Adult patients (18 years or older) who were diagnosed
with an ACS (i.e., AMI or UA) were recruited by a research
nurse on the second to the fifth day of their hospitalization.
This was a longitudinal observational study on depression
and participation in cardiac rehabilitation that assessed
patients in the hospital and by then at 6 and 12 months
post-ACS by mail. Patients were recruited from 12 coronary
care units in both large urban teaching hospitals and
community hospitals in small- and medium-sized cities
across Southcentral Ontario, Canada. Patients were excluded
if they were medically unstable or unable to read or speak
English. Eligible patients who agreed to participate gave
informed, written consent and were provided with a self-
report questionnaire. All patients received standard care for
their ACS. The original study protocol was approved by the
Research Ethics Boards of the University of Toronto and
University Health Network.
Measures
The SF-12 [7] was administered during the hospitaliza-
tion, and the PCS and MCS were used to measure physical
and mental health status, respectively. High scores on the
PCS indicate better function, whereas low scores reflect
important physical limitations, including difficulties in self-
care, physical and social activities, and role performance;
high levels ofpain; and/or fatigue [7]. Similarly, high scores
on the MCS suggest the positive affect and absence of
psychological distress, whereas low scores are indicative of
poorer mental health, including high levels of psychological
distress and social and role limitations due to emotional
problems [7]. The SF-12 [7] is a 12-item version ofthe SF-36
[6]. A large longitudinal study of patients with coronary
heart disease found that the SF-12 PCS and MCS were
highly correlated with their respective summary scores on
the SF-36 (both r=.96, P<.OOI). Change over time on the
SF-36 PCS and MCS was also closely replicated by the SF-
12 PCS (r=.95, P<.OOI) and MCS (r=.94, P<.OOI) [22].
Raw scores on the SF-12 PCS and MCS are standardized to
the general US population (mean=50, S.D.=IO) to facilitate
interpretation [7].
Symptoms of depression were assessed using the 2I-item
Beck Depression Inventory (BD!) [23]. Each item has four
possible answers, scored 0-3, indicating increasing symp-
tom severity, and respondents are instructed to describe the
way they have been feeling during the past week. The BDI is
the most widely used measure of depressive symptoms in
studies of patients with ACS [24].
Killip class [25], measured on a four-point scale, was
used to indicate the presence of heart failure on admission to
the hospital. Killip class is a simple clinical tool that has
been found in many studies to predict mortality following
ACS [26-28]. Killip class and history of previous AMI
were determined from the medical record. Sociodemo-
graphic data and other health status variables, such as
comorbidities and smoking status, were determined from
the patient health questionnaire.
The primary outcome variable was all-cause mortality
within 12 months of discharge from the hospital. For
patients who did not return l2-month follow-up ques-
tionnaires, vital status was determined by contacting by
telephone, in sequence as necessary, patients, patients'
family members or contacts listed in the initial data
collection form, patients' general practitioners, and
patients' specialist physicians.
Data analysis
Patient demographic and medical data were compared
between patients who died and patients who survived to 12
months post-discharge using the l statistic for categorical
variables and t tests for continuous variables. The associa-
tions of the SF-12 PCS and MCS with l2-month mortality
were assessed separately with logistic regression models,
rather than with survival models, since survival status at 12
months was available, but data on time to death were not. For
both the SF-12 PCS and MCS, the component summary
score was initially entered alone, followed by a second
model with known demographic and cardiac risk factors
[age, sex, cardiac diagnosis (AMI vs. UA), history of MI,
and Killip class], followed by a third model that added in-
hospital BDI scores. The set of covariates was limited to
these variables based on consideration of the number of
outcomes (mortality) being predicted. Additional covariates
were added to the third model post hoc one at a time to
determine whether they would have likely changed the
association between the PCS or MCS and mortality. Based
on the overall mortality rate of 5.6%, the study had 80%
power to detect an increase in mortality of48% per decrease
of 10 points (1 SD in the normative sample) in PCS and MCS
scores. Discrimination and calibration of the multivariate
models were assessed based on the c-index and the Hosmer-
Lemeshow goodness-of-fit test statistic, respectively [29].
The c-index is the percentage ofcomparisons where patients
who died had a higher predicted probability of death than
patients who lived for all possible patient pairs, one ofwhom
lived to 12 months post-discharge and the other of whom
died by 12 months post-discharge [29]. Calibration was
assessed using the Hosmer-Lemeshow goodness-of-fit test
(HL) [29], which is a measure of the accuracy of the
predicted number of deaths compared to the number of
patients who actually die across the spectrum of probabil-
ities. A relatively large P value indicates that the model fits
well and that there is not a large discrepancy between
observed and expected mortality. All analyses were
conducted using SPSS version 15.0 (SPSS, Inc, Chicago,
IL, USA), and all statistical tests were two-sided with a
P<.05 significance level.
Results
SF-l2, sociodemographic, cardiac disease, and risk factor
data were available from 812 patients in-hospital, and 800
had l2-month mortality data (45 deaths, 5.6%). As shown in
Table 1, patients who died within 12 months of discharge
were significantly older, more likely to have high school
Table I
Participants who were alive vs. those who died 12 months after discharge
All patients Dead at 12 months Alive at 12 months P value
Total number 800 45 (5.6%) 755 (94.4%)
Sociodemographics
Age in years, mean±S.D. 61.5±11.9 68.3±1l.l 61.1±11.9 <.001
Male,n 533/800 (66.6%) 32/45 (71.1%) 501/755 (66.4%) .511
Family income >Can$50,000, n 310/688 (45.1%) 11/36 (30.6%) 299/652 (45.9%) .072
Married,n 593/791 (75.0%) 30/45 (66.7%) 563/746 (75.5%) .186
Education high school or less, n 541/782 (69.2%) 36/43 (83.7%) 505/739 (68.3%) .034
Health
Diagnosis of AMI, n 428/800 (53.5%) 24/45 (53.3%) 4041755 (53.5%) .982
Killip class >1, n 126/800 (15.8%) 11/45 (24.4%) 115/755 (15.2%) .099
Peak creatinine kinase (IV), mean±S.D. a 1302±1507 1328±151O 825±138I .128
Systolic blood pressure>130 mmHg, n 459/796 (57.7%) 23/45 (51.1 %) 436/751 (58.1%) .360
Diabetes mellitus, n 188/741 (25.4%) 14/43 (32.6%) 174/698 (24.9%) .264
Smoker, n 264/778 (33.9%) 14/44 (31.8%) 250/734 (34.1 %) .760
Previous MI, n 228/800 (28.5%) 25/45 (55.6%) 2031756 (26.9%) <.001
History of CABG 76/788 (9.6%) 6/45 (13.3%) 70/743 (9.4%) .430
History of PTCA 42/788 (5.3%) 3/45 (6.7%) 39/743 (5.2%) .727
Physical function and depression
SF-12 PCS Score, mean±S.D. 40.5±11.5 33.2±9.8 41.0±11.5 <.001
SF-12 MCS Score, mean±S.D. 48.5±1O.9 45.5±11.4 48.7±1O.8 .051
BDI score, mean±S.D. 8.7±7.4 12.3±8.8 8.5±7.3 .006
BD! ~IO, n 275/800 (34.4%) 23/45 (51.1%) 252/755 (33.4%) .015
For certain items in the table, there are missing data as reflected in the denominators. For the SF-12 PCS and MCS scores, a higher score reflects better function. For
the BDI, a higher score reflects greater depressive symptoms. CABG=Coronary artery bypass graft; PTCA=percutaneous transluminal coronary angioplasty.
a Peak creatinine kinase reported only for patients with a diagnosis of AMI.
Discussion
For the SF-12 MCS score, a higher score reflects better function. For the
BDI, a higher score reflects greater depressive symptomatology.
Table 3
Results from hierarchical logistic regression analyses predicting mortality
using SF-12 MCS score with and without adjustment for other prog-
nostic factors
depression were included in the model, higher symptoms of
depression were significantly associated with greater mor-
tality risk (OR=1.07, CI=1.02-1.12, P=.003), but the SF-12
MCS was not (OR=0.99, CI=0.96-1.02, P=.534). In
addition, age and history of MI significantly predicted
mortality in both regression models. Sex was a significant
predictor in some, but not all, models. The final models for
both PCS and MCS had good discriminative power (c-
index=.79 and .77, respectively) and calibration (P=.424 and
P=.423 for HL statistic, respectively). Post hoc analysis with
additional variables from Table 1 included as covariates did
not alter findings related to the PCS or MCS.
.534
<.001
.027
.338
.009
.668
.003
0.96-1.02
1.04-I.I I
0.20-0.91
0.72-2.64
1.25-4.52
0.55-2.53
1.02- I.I2
Odds 95% Confidence
ratio interval P value
0.98 0.95-1.00 .053
0.96 0.93-0.99 .010
1.06 1.03-I.IO <.001
0.52 0.25-1.07 .075
1.25 0.66-2.36 .503
2.56 1.35-4.82 .004
1.40 0.66-2.96 .384
Variable
MCS
SF-12 MCS Score
MCS+demographic and
cardiac prognostic factors
SF-12 MCS Score
Age
Female sex
Diagnosis of AMI (vs. UA)
Previous MI
KiIIip class > I
MCS+demographic and cardiac
prognostic factors+depressive
symptoms
SF-12 MCS Score 0.99
Age 1.07
Female sex 0.43
Diagnosis of AMI (vs. UA) 1.38
Previous MI 2.37
KiIlip class > I I.I 8
BDI Total score 1.07
The main finding of this study was that physical health
status assessed during hospitalization for AMI or UA
independently predicted mortality 1 year later even after
adjusting for traditional clinical risk factors and symptoms
of depression. A decrease of 10 points (1 SD in the
normative sample) in PCS scores on the SF-12 was
associated with a 34% higher risk of mortality 12 months
after an ACS. In-hospital MCS scores, on the other hand,
tended to predict mortality in bivariate analysis (nonsigni-
ficant), but were not a factor in multivariate analysis after
controlling for risk factors, including depressive symptoms.
The relationship of symptoms of depression with mortality
was significant when included in prognostic models with
the PCS or the MCS, and each I-point increase in total BDI
Table 2
Results from hierarchical logistic regression analyses predicting mortality
using SF-12 PCS score with and without adjustment for other prog-
nostic factors
95% Confidence
Variable Odds ratio interval P value
PCS
SF-12 PCS Score 0.94 0.92-0.97 <.001
PCS+demographic and
cardiac prognostic factors
SF-12 PCS Score 0.95 0.92-0.98 <.001
Age 1.05 1.02-1.08 .004
Female sex 0.49 0.24-1.02 .055
Diagnosis of AMI (vs. UA) 1.47 0.76-2.83 .252
Previous MI 2.23 I.I7-4.25 .015
KiIIip class > I 1.20 0.54-2.48 .642
PCS+demographic and cardiac
prognostic factors+depressive
symptoms
SF-12 PCS Score 0.96 0.93-0.99 .008
Age 1.06 1.03-I.IO <.001
Female sex 0.39 0.18-0.82 .013
Diagnosis of AMI (vs. UA) 1.63 0.84-3.17 .151
Previous MI 2.09 1.09-4.01 .027
KiIIip class> I 1.03 0.47-2.22 .951
BDI Total score 1.07 1.03-I.I I .001
For the SF-12 PCS score, a higher score reflects better function. For the
BDI, a higher score reflects greater depressive symptomatology.
education or less, and more likely to have had a previous MI.
They rated their physical health status significantly worse
based on the PCS and had more symptoms of depression.
There was a nonsignificant trend for MCS scores to be lower
and for Killip class to be >I among patients who died within
12 months post-ACS. PCS scores among patients who died
were 33.2 (1.68 SDs below the US general population mean)
compared to 41.0 (0.9 SD below the mean for the US
population) among patients alive at 12 months post-
discharge. MCS scores for patients who died in the first 12
months post-discharge were 45.5 (0.45 SD below the US
general population mean) compared to 48.7 (0.13 SD below
the US general population mean) for patients who survived
to 12 months post-discharge. BDI scores were significantly
correlated with both PCS (r=-.33, P<.OOI) and MCS scores
(r=-.60, P<.OOI).
On a bivariate basis, lower scores on the SF-12 PCS were
associated with a significantly higher risk of mortality [odds
ratio (OR)=0.94, 95% confidence interval (CI)=0.92-0.97,
P<.OOI] (Table 2), whereas MCS scores failed to reach
significance (OR=0.98, CI=0.95-1.00, P=.053) (Table 3).
The PCS continued to significantly predict 12-month
mortality even after controlling for other demographic and
cardiac risk factors and depressive symptoms (OR=0.96,
CI=O.93-0.99, P=.008). This reflects risk per I-point change
in PCS that is equivalent to a 34% increase in risk of 12-
month mortality per lO-point (1 SD) decrement in PCS
scores. The MCS was a significant predictor of mortality
after adjusting for demographic and cardiac risk factors
(OR=0.96, CI=0.93-0.99, P=.OlO). When symptoms of
score was associated with a 7% higher risk of death. Thus,
in addition to patient-reported physical health, patient-
reported mental health as assessed by the BDI, but not the
MCS, predicted 12-month mortality.
The finding that the PCS, but not the MCS, predicts
mortality is consistent with the results of studies of patients
undergoing CABG surgery [4] and hospitalized heart failure
patients [14], in which the SF-36 PCS, but not the MCS,
predicted mortality approximately 6 months after hospital
discharge. Studies of heart failure patients that have used
other measures of self-reported health status, such as the
Minnesota Living with Heart Failure Questionnaire, the
Seattle Angina Questionnaire, or the Nottingham Health
Profile, have generally found that global and/or physical
health status scores significantly predict mortality in multi-
variate analyses, but that the relationship between mental or
emotional health and mortality varies across studies [10-15].
One recent study reported that after controlling for cardiac
risk factors and symptoms of depression, mortality was not
related to the SF-36 PCS, the SF-36 MCS, or the clinical
summary score of the Kansas City Cardiomyopathy Ques-
tionnaire. The authors attributed this finding to the robust
prognostic power of the New York Heart Association
functional class variable, although it is possible that
relatively small sample size was also a factor (N=23 1) [16].
It is notable in the present study that the SF-12 MCS was
not a significant predictor of mortality, whereas the BD! was
a significant and strong predictor of mortality. This may
relate to how the SF-12 summary scores are calculated and,
specifically, to the use of negative scoring coefficients to
calculate the summary scores. The scoring methods for
calculating the PCS and MCS summary scores of the SF-36
and SF-12 were designed to create orthogonal (uncorrelated)
factor scores in order to eliminate the problem of multi-
collinearity when using both component scores in multiple
regression. To achieve this, low scores on some of the
physically oriented items (poor functioning) are scored
negatively on the MCS, resulting in better mental function
scores. The opposite is also true. Farivar et al. [30] recently
demonstrated that when physical subscale scores are well
below the mean and mental subscale scores somewhat less
below the mean, as is often the case in patients with medical
illness, this scoring method will result in an artifactual
migration of the aggregate PCS score away from the mean
and a migration of the aggregate MCS score towards the
mean. This phenomenon can be illustrated by comparing SF-
36 physical subscale scores with the PCS and SF-36 mental
subscale scores with the MCS; the study ofhospitalized heart
failure patients by Rodriguez-Artalejo et al. [14] provides
such data. In that study, patient scores on the physical
subscales (physical functioning, physical role, bodily pain,
general health perception) were 0.3 to 2.0 SDs (mean 1.3
SDs) lower than the US general population (http://www.
sf-36.orglnbscalc/index.shtml), and the PCS score was
approximately 1.6 SDs below the general population mean.
Scores on the mental subscales (mental health, emotional
role, vitality, social functioning) were 0.7 to 1.2 SDs lower
than the US general population scores (mean 0.9 SDs), but
the MCS was only 0.6 SDs lower than the US population
standardization sample mean. An important implication of
this scoring artifact is that relationships between mental
health factors and outcomes of interest may be dampened
sufficiently when combined in the aggregate scores to not be
detected [31]. Although this phenomenon is less easily
illustrated for the SF-12 aggregate scores, it is similarly
present. Another possible reason is that the 21-item BD! was
a more reliable predictor than the shorter SF-12 MCS.
Thus, both the BD! and the SF-12 PCS were useful in
predicting mortality at 12 months and would be useful risk
stratification tools in the post-ACS setting. Depression is a
well-known risk factor for post-ACS mortality and is
associated with functional impairment [32], less favorable
self-care behaviors [33], higher health care costs [34], and
increased cardiac morbidity and mortality [18,35]. Self-rated
physical health may quantify underlying aspects of health
not captured by traditional indicators ofdisease severity or it
may serve as a proxy when these indicators are not available.
Physical health may also quantify important aspects ofhealth
not related to cardiovascular disease. In terms of prevention
and rehabilitation, this study shows that a broad approach to
conceptualizing post-ACS health may be useful for under-
standing risk. Although the BD! and PCS may both be useful
for risk stratification, this study does not provide sufficient
data to recommend that either be used as part of the routine
care of ACS patients. As demonstrated in primary care
settings for depression, improved outcomes from depression
screening are dependent upon the use of integrative care
models including the use of evidence-based protocols for
treatment, active collaboration between primary care provi-
ders and mental health specialists, active monitoring of
adherence to therapy, and access to structured psychotherapy
[36-38]. Thus far, no studies have tested whether screening
for depression or self-rated health status benefits patients in
cardiovascular care settings.
A limitation of this study was that mortality was assessed
only at 12 months post-ACS, which did not provide time to
death data. Thus, logistic regression was conducted, rather
than survival analysis, which could have affected results.
The 12-month assessment point was arbitrary, and it is not
known whether the results produced by the regression model
at 12 months would have been the same at other time points
(e.g., 24 or 36 months). Mortality data did not include
whether or not death was cardiac related and was done via
report of patients' family members, general practitioners, or
specialist physicians, the accuracy of which has not been
demonstrated. In addition, there were a relatively small
number of deaths, and it is not known whether the risk
estimates generated from this sample would be replicated in
a larger sample with more deaths. The small number of
deaths may also explain why Killip class, for instance, which
has been strongly and consistently related to mortality risk
factor in previous studies [25-28], showed a trend towards
higher mortality in bivariate analysis, but did not reach
statistical significance. An additional limitation was that
information was not available on several important risk
markers, including left ventricular ejection fraction, renal
function, revascularization procedures, or medications used.
Thus, it is possible that our results may reflect some degree
of residual confounding.
In conclusion, the pes of the SF-12 presents an attractive
option for improving risk stratification since it significantly
predicts mortality and may detect aspects of physical health
and mortality risk that may not be captured by more
commonly used indicators of cardiac disease severity or by
other traditional risk factors. The association of self-rated
physical health should be tested in future studies that control
for a broader spectrum of risk factors than were available in
this study.
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